4.7 Article

A Randomized Study on 1-Week Versus 4-Week Prophylaxis for Venous Thromboembolism After Laparoscopic Surgery for Colorectal Cancer

期刊

ANNALS OF SURGERY
卷 259, 期 4, 页码 665-669

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/SLA.0000000000000340

关键词

antithrombotic prophylaxis; colorectal cancer; laparoscopic surgery; venous thromboembolism

类别

向作者/读者索取更多资源

Objective: To compare the efficacy and safety of antithrombotic prophylaxis given for 1 week or 4 weeks in patients undergoing laparoscopic surgery for colorectal cancer. Background: Extending antithrombotic prophylaxis beyond 1 week reduces the incidence of venous thromboembolism (VTE) after open abdominal surgery for cancer. Methods: In consecutive patients who underwent laparoscopic surgery for colorectal cancer, complete compression ultrasonography of the lower limbs was performed after 8 2 days of antithrombotic prophylaxis. Patients with no evidence of VTE were randomized to short (heparin withdrawal) or to extended (heparin continued for 3 additional weeks) prophylaxis. Complete compression ultrasonography was repeated at day 28 2 after surgery by investigators blinded to treatment allocation. The primary outcome of the study was the composite of symptomatic and ultrasonography-detected VTE at day 28 +/- 2 after surgery. Results: Overall, 301 patients were evaluated for inclusion in the study and 225 were randomized. VTE occurred in 11 of 113 patients randomized to short (9.7%) and in none of the 112 patients randomized to extended heparin prophylaxis (P = 0.001). The incidence of VTE at 3 months was 9.7% and 0.9% in patients randomized to short or to extended heparin prophylaxis, respectively (relative risk reduction: 91%, 95% confidence interval: 30%-99%; P = 0.005). The rate of bleeding was similar in the 2 treatment groups. Two patients died during the study period, 1 in each treatment group. Conclusions: After laparoscopic surgery for colorectal cancer, extended antithrombotic prophylaxis is safe and reduces the risk for VTE as compared with 1-week prophylaxis (NCT01589146).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Surgery

Robotic Resection of Giant Duodenal Hamartoma After 18Fluorodeoxyglucose Positron Emission Tomography Magnetic Resonance Imaging (18FDG PET-MRI)

Emanuele Damiano Luca Urso, Filippo Crimi, Giorgio Rivella, Francesco Celotto, Pietro Zucchetta, Laura Albertoni, Salvatore Pucciarelli, Quoc Riccardo Bao

Summary: This study reports a rare case of duodenal lesion in a 41-year-old female patient, which was evaluated for malignant potential and treatment planning using clinical staging and (18)FDG PET/MRI. Robotic transduodenal excision was performed based on the findings. The study suggests that accurate staging with (18)FDG PET/MRI can be very useful in the management of duodenal lesions with uncertain malignant potential.

AMERICAN SURGEON (2023)

Article Pathology

MMR profile and microsatellite instability status in colorectal mucinous adenocarcinoma with synchronous metastasis: a new clue for the clinical practice

Paola Parente, Umberto Malapelle, Valentina Angerilli, Mariangela Balistreri, Sara Lonardi, Salvatore Pucciarelli, Caterina De Luca, Francesco Pepe, Gianluca Russo, Elena Vigliar, Angela Danza, Fabio Scaramuzzi, Giancarlo Troncone, Paolo Graziano, Matteo Fassan

Summary: This study assessed the concordance rate of MMR/MSI status between primary mucinous adenocarcinoma (MA) and synchronous metastasis. The results showed high concordance rates using different evaluation methods. Therefore, integrating immunohistochemistry evaluation and molecular methods may be beneficial for molecular profiling of MA patients.

JOURNAL OF CLINICAL PATHOLOGY (2023)

Article Gastroenterology & Hepatology

Molecular determinants of peritoneal dissemination in gastric adenocarcinoma

Valentina Mari, Valentina Angerilli, Giada Munari, Marco Scarpa, Quoc Riccardo Bao, Salvatore Pucciarelli, Matteo Fassan, Gaya Spolverato

Summary: This review outlines the molecular pathways involved in peritoneal metastatic dissemination in gastric cancer, highlighting the lack of comprehensive understanding of the complex molecular landscape of this disease. The integration of molecular profiling and histological evaluation is recommended for risk prediction assessment of peritoneal dissemination.

DIGESTIVE DISEASES (2023)

Article Surgery

Minimally invasive vs. open segmental resection of the splenic flexure for cancer: a nationwide study of the Italian Society of Surgical Oncology-Colorectal Cancer Network (SICO-CNN)

Maurizio Degiuli, Monica Ortenzi, Mariano Tomatis, Lucia Puca, Desiree Cianflocca, Daniela Rega, Annalisa Maroli, Ugo Elmore, Francesca Pecchini, Marco Milone, Roberta La Mendola, Erica Soligo, Simona Deidda, Domenico Spoletini, Diletta Cassini, Alessandra Aprile, Michela Mineccia, Herald Nikaj, Francesco Marchegiani, Fabio Maiello, Cristina Bombardini, Michele Zuolo, Michele Carlucci, Luca Ferraro, Armando Falato, Alberto Biondi, Roberto Persiani, Patrizia Marsanich, Daniele Fusario, Leonardo Solaini, Sara Pollesel, Gianluca Rizzo, Claudio Coco, Alberto Di Leo, Davide Cavaliere, Franco Roviello, Andrea Muratore, Domenico D'Ugo, Francesco Bianco, Paolo Pietro Bianchi, Paola De Nardi, Marco Rigamonti, Gabriele Anania, Claudio Belluco, Roberto Polastri, Salvatore Pucciarelli, Sergio Gentilli, Alessandro Ferrero, Stefano Scabini, Gianandrea Baldazzi, Massimo Carlini, Angelo Restivo, Silvio Testa, Dario Parini, Giovanni Domenico De Palma, Micaela Piccoli, Riccardo Rosati, Antonino Spinelli, Paolo Delrio, Felice Borghi, Marco Guerrieri, Rossella Reddavid

Summary: This study investigated the efficacy and short-term outcomes of minimally invasive (MI) and open treatment for splenic flexure cancer (SFC). The results showed that MI was noninferior to open procedure in terms of postoperative complications and pathological outcomes in SFC patients.

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2023)

Article Gastroenterology & Hepatology

Limits of Clinical Restaging in Detecting Responders After Neoadjuvant Therapies for Rectal Cancer

Simona Deidda, Gaya Spolverato, Giulia Capelli, Riccardo Quoc Bao, Lorenzo Bettoni, Filippo Crimi, Luigi Zorcolo, Salvatore Pucciarelli, Angelo Restivo

Summary: This study retrospectively reviewed the clinical restaging of rectal cancer after neoadjuvant therapy, and found limitations in accurately detecting the complete pathological response to treatment. Current clinical assessments need to be revised to account for indications for rectal preservation after neoadjuvant chemoradiotherapy.

DISEASES OF THE COLON & RECTUM (2023)

Article Medicine, General & Internal

Efficacy and safety of two heparin regimens for prevention of venous thromboembolism in hospitalized patients with COVID-19: a meta-analysis

Maria Cristina Vedovati, Mara Graziani, Giancarlo Agnelli, Cecilia Becattini

Summary: This study aimed to evaluate the efficacy and safety of standard or higher heparin regimens for the prevention of venous thromboembolism (VTE) in hospitalized patients with COVID-19. The study found that high-dose heparin prophylaxis reduces the risk of VTE but increases the risk of major bleeding (MB). High-dose heparin did not show clinical benefit in the ICU setting but may have some benefit in the non-ICU setting.

INTERNAL AND EMERGENCY MEDICINE (2023)

Review Oncology

Rectal Sparing Approaches after Neoadjuvant Treatment for Rectal Cancer: A Systematic Review and Meta-Analysis Comparing Local Excision and Watch and Wait

Quoc Riccardo Bao, Stefania Ferrari, Giulia Capelli, Cesare Ruffolo, Marco Scarpa, Amedea Agnes, Giuditta Chiloiro, Elisa Palazzari, Emanuele Damiano Luca Urso, Salvatore Pucciarelli, Gaya Spolverato

Summary: With the increasing rate of complete response after neoadjuvant treatment for locally advanced rectal cancer, there has been growing interest in rectal-sparing approaches such as local excision and Watch and Wait. This study aimed to systematically review the literature and compare these approaches in terms of rectum-preservation rate, local control, and distant recurrences. The findings showed no significant differences between Watch and Wait and local excision in these outcomes. Rating: 7/10

CANCERS (2023)

Letter Hematology

DOACs in patients with brain cancers: promising but still a long way to go

Michela Giustozzi, Cecilia Becattini, Fausto Roila, Giancarlo Agnelli, Mario Mandala

BLOOD ADVANCES (2023)

Article Medicine, General & Internal

Risk factors for recurrence and major bleeding in patients with cancer-associated venous thromboembolism

Maria Cristina Vedovati, Michela Giustozzi, Andres Munoz, Laurent Bertoletti, Alexander T. Cohen, Frederikus A. Klok, Jean M. Connors, Rupert Bauersachs, Benjamin Brenner, Mauro Campanini, Cecilia Becattini, Giancarlo Agnelli

Summary: Patients with cancer-associated venous thromboembolism (VTE) face high risks of recurrence and treatment-emergent bleeding, but factors associated with these risks are not well-defined. This study analyzed patients included in the Caravaggio study to identify risk factors for recurrent VTE and major bleeding in cancer-associated VTE. Independent risk factors for recurrent VTE included deep vein thrombosis as the initial event, ECOG status of 1 or more, pancreatic or hepatobiliary cancer site, concomitant anti-cancer treatment, and creatinine clearance. Independent risk factors for major bleeding included ECOG status of 2, genitourinary or upper gastrointestinal cancer site, and non-resected luminal gastrointestinal cancer. Understanding these predictors can help optimize anticoagulant treatment in cancer-associated VTE patients.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2023)

Article Gastroenterology & Hepatology

Prognostic value of major pathological response following neoadjuvant therapy for non resectable pancreatic ductal adenocarcinoma

Quoc Riccardo Bao, Isabella Frigerio, Marzia Tripepi, Stefano Marletta, Guido Martignoni, Alessandro Giardino, Paolo Regi, Filippo Scopelliti, Valentina Allegrini, Roberto Girelli, Salvatore Pucciarelli, Gaya Spolverato, Giovanni Butturini

Summary: This study aimed to evaluate the impact of major pathological response on overall survival in patients with borderline resectable and locally advanced pancreatic ductal adenocarcinoma following neoadjuvant treatment, and to identify predictors of major pathological response. The study included 200 patients who underwent surgical resection after neoadjuvant treatment. The results showed that patients with major pathological response had higher overall survival rates compared to those without major pathological response. CA19-9 normalization and radiological post-treatment tumor size were found to be independent predictors of major pathological response.

PANCREATOLOGY (2023)

Article Pathology

Impact of DNA mismatch repair proteins deficiency on number and ratio of lymph nodal metastases in colorectal adenocarcinoma

Federica Zannier, Valentina Angerilli, Gaya Spolverato, Stefano Brignola, Daniele Sandona, Mariangela Balistreri, Marianna Sabbadin, Sara Lonardi, Francesca Bergamo, Claudia Mescoli, Marco Scarpa, Quoc Riccardo Bao, Angelo Paolo Dei Tos, Salvatore Pucciarelli, Emanuele L. D. Urso, Matteo Fassan

Summary: This study aimed to compare the pathological and clinical characteristics of MMR-deficient (MMRd) tumors and MMR proficient (MMRp) cases, with a particular focus on the relationship between these molecular subgroups and lymph node ratio (LNR). The study found significant differences between MMRd and MMRp tumors in terms of sex, age, size, growth pattern, inflammatory infiltrate, perineural invasion, stage, grade, and LNR. In conclusion, MMRd tumors are a distinct molecular subtype of colorectal cancer characterized by a significantly lower LNR, further supporting the prognostic impact of MMRd status in early-stage CRC.

PATHOLOGY RESEARCH AND PRACTICE (2023)

Article Surgery

Leaving behind a diseased small bowel during surgery for Crohn's disease: Long-term outcomes

Imerio Angriman, Silvia Degasperi, Claudia Mescoli, Carmelo Lacognata, Claudia Armellin, Antonino Caruso, Federico Scognamiglio, Matteo Fassan, Renata D'Inca, Edoardo Savarino, Fabiana Zingone, Gaya Spolverato, Salvatore Pucciarelli, Romeo Bardini, Cesare Ruffolo, Marco Scarpa

Summary: This retrospective study analyzed the intestinal and systemic inflammation after surgery in Crohn's disease patients with strictures where the diseased bowel was left behind. The results showed that the intestinal inflammatory activity decreased even with the preservation of the diseased bowel, but the presence of the diseased bowel increased the risk of reoperation.

SURGERY TODAY (2023)

Article Nutrition & Dietetics

Resident Esophageal Microbiota Dysbiosis Correlates with Cancer Risk in Barrett's Esophagus Patients and Is Linked to Low Adherence to WCRF/AICR Lifestyle Recommendations

Alice Zaramella, Diletta Arcidiacono, Daniele Nucci, Federico Fabris, Clara Benna, Salvatore Pucciarelli, Matteo Fassan, Alberto Fantin, Valli De Re, Renato Cannizzaro, Stefano Realdon

Summary: Esophageal adenocarcinoma (EAC) is a consequence of long-term gastroesophageal reflux, which leads to inflammation and could cause Barrett's esophagus (BE), the main risk factor for EAC development. The study aims to explore the esophageal microbial profile in patients with different stages of BE and EAC, and develop a score to predict cancer risk.

NUTRIENTS (2023)

Review Cardiac & Cardiovascular Systems

Early predictors of clinical deterioration in intermediate-high risk pulmonary embolism: clinical needs, research imperatives, and pathways forward

Marco Zuin, Cecilia Becattini, Gregory Piazza

Summary: The present article aims to identify the current unmet needs related to the early identification of intermediate-high risk PE patients at higher risk of clinical deterioration and mortality during the early hours after the acute cardiovascular event and suggest some potential strategies to further explore gaps in the literature.

EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2023)

Article Surgery

IMMUNOREACT 6: weak immune surveillance characterizes early-onset rectal cancer

Gaya Spolverato, Matteo Fassan, Melania Scarpa, Astghik Stepanyan, Ottavia De Simoni, Federico Scognamiglio, Valentina Chiminazzo, Clarissa De Nardi, Giulia Tamponi, Silvia Negro, Imerio Angriman, Andromachi Kotsafti, Cesare Ruffolo, Chiara Vignotto, Maurizio Zizzo, Francesco Marchegiani, Luca Facci, Francesca Bergamo, Stefano Brignola, Gianluca Businello, Vincenza Guzzardo, Luca Dal Santo, Roberta Salmaso, Carlotta Ceccon, Marco Massani, Anna Pozza, Ivana Cataldo, Tommaso Stecca, Angelo Paolo Dei Tos, Vittorina Zagonel, Pierluigi Pilati, Boris Franzato, Antonio Scapinello, Giovanni Pirozzolo, Alfonso Recordare, Roberto Merenda, Giovanni Bordignon, Licia Laurino, Silvio Guerriero, Chiara Romiti, Giuseppe Portale, Chiara Cipollari, Salvatore Candioli, Laura Gavagna, Giulia Pozza, Mario Godina, Isabella Mondi, Giulia Noaro, Monica Ortenzi, Mario Guerrieri, Giovanni Tagliente, Monica Tomassi, Umberto Tedeschi, Andrea Porzionato, Marco Agostini, Isacco Maretto, Quoc Riccardo Bao, Francesco Cavallin, Barbara Di Camillo, Romeo Bardini, Ignazio Castagliuolo, Salvatore Pucciarelli, Marco Scarpa

Summary: The study found that early-onset rectal cancer is rarely associated with common hereditary syndromes. The tumor microenvironment is characterized by a high frequency of mutations impairing the local immune surveillance mechanisms and low expression of immune editing-related genes. A constitutively low number of CD4 T cells associated with a high number of T regulators indicates an imbalance in the immune surveillance mechanisms.

BRITISH JOURNAL OF SURGERY (2023)

暂无数据